CareDx Made Transplant Care Less Invasive. Then Its Own Business Needed Surgery.

The transplant diagnostics company turned fragments of donor DNA into a recurring-care business. A 2023 reimbursement shock forced a reset - and revealed a playbook built on narrow markets, repeat tests, and one very deep customer relationship.